Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

Oppenheimer Asset Management Inc. raised its position in shares of Veralto Co. (NYSE:VLTO – Free Report) by 13.0% in the ...

Oppenheimer Asset Management Inc. lessened its position in Invesco S&P 500 High Beta ETF (NYSEARCA:SPHB – Free Report) by ...

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

At the Oscars, ‘Anora’ director Sean Baker urged Hollywood not to give up on local cinemas. In New Jersey, theaters are ...

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...

Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.

Despite challenges, LI movie theaters are seeing a resurgence, with new investments and innovative approaches to attract ...

Tactile Systems Technology, Inc. ("Tactile Medical”; the "Company”) (Nasdaq: TCMD), a medical technology company providing ...

Oppenheimer analyst Jay Olson lowered the firm’s price target on Denali Therapeutics (DNLI) to $42 from $50 and keeps an Outperform rating on the shares following quarterly results and after hosting ...